Related Experiment Video
Updated: Aug 9, 2026

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
[Hypnotically active blood level of midazolam]
Abstract:
Midazolam was administered to seven healthy adult volunteers by microprocessor controlled infusions that generated 3 cycles of lineary increasing plasma levels with an anticipated slope of 20 ng ml-1 min-1. When a deep unconscious status was obtained as indicated by no response to loud verbal stimuli, the concentrations were kept constant at that plateau for 30 min. Thereafter, the infusions were stopped and restarted when the volunteers were again fully responsive to acoustic stimuli of normal intensity. Frequent venous blood samples were obtained during and after the infusions to evaluate venous threshold concentrations of induced sleep and recurrence of orientation, loss and recurrence of eyelid-reflex (and corneal reflex), and unconsciousness and recovery of responsiveness to loud verbal stimuli. From the first to the third infusion cycle a slight, but not significant increase of mean threshold concentrations could be observed. Hence, they were averaged over all infusion cycles. In detail, the following concentrations (in ng/ml; mean +/- SD) resulted: asleep: 251 +/- 110 and oriented: 277 +/- 107, loss: 543 +/- 173 and recurrence of eye-lid reflex: 532 +/- 120, unconsciousness: 575 +/- 128 and recovery to responsiveness: 555 +/- 151. In all but one volunteer, the corneal reflex could be triggered at any time. Hence, a mean threshold concentration of that, observation could not be obtained. Phenomena of acute tolerance that should lead to significant increases of threshold concentrations from the first to the last infusion cycle could not be demonstrated.
Insights
This study found that midazolam (MDZ) plasma concentrations required to induce and reverse unconsciousness in healthy volunteers remained consistent across multiple infusion cycles. Acute tolerance to midazolam was not observed.
Area of Science:
- Pharmacology
- Neuroscience
Context:
- Midazolam is a widely used sedative-hypnotic agent.
- Understanding its dose-response relationship is crucial for safe clinical application.
Purpose:
- To determine the venous threshold concentrations of midazolam for various levels of consciousness and reflexes.
- To investigate the potential development of acute tolerance to midazolam during repeated infusions.
Summary:
- Healthy volunteers received controlled midazolam infusions to assess plasma concentrations for sleep induction, loss of responsiveness, and recovery.
- Threshold concentrations for different endpoints, including eyelid reflex and orientation, were measured across three infusion cycles.
- No significant increase in threshold concentrations was observed, indicating a lack of acute tolerance.
Impact:
- Provides precise pharmacokinetic data for midazolam's sedative effects.
- Informs clinical practice regarding optimal dosing and monitoring of midazolam infusions.
- Contributes to the understanding of drug tolerance mechanisms.
More Related Videos
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Local Anesthetics: Pharmacokinetics
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview